PharmaEssentia (TWSE: 6446) today announced its net revenues for September 2025: On a consolidated basis, revenues for September 2025 were approximately NT$1.32 billion, an increase of 3.44% from August 2025 and an increase of 41.34% from August 2024. The year-to-date consolidated revenue totaled NT$10.75 billion, an increase of 61.14%.